Abstract
Following mastectomy, patients with operable breast cancer underwent postoperative irradiation of the chest wall and regional lymph nodes. They were then assigned at random to receive no further therapy, ovarian irradiation (2000 rads in 5 days) or ovarian irradiation in the same dosage plus prednisone, 7.5 mg daily. A total of 705 patients received the randomly assigned treatment and were followed for up to 10 years. In premenopausal patients who received ovarian irradiation the recurrence of breast cancer was delayed and survival prolonged, but not significantly. In premenopausal women aged 45 years or more ovarian irradiation plus prednisone therapy significantly delayed the recurrence of breast cancer (P = 0.02) and prolonged survival (P = 0.02); the survival expectancy of these patients was similar to that of the general population of the same age from the third year after the cancer operation. No value was demonstrated for ovarian irradiation with or without prednisone therapy in postmenopausal patients.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brinkley D., Haybrittle J. L. The curability of breast cancer. Lancet. 1975 Jul 19;2(7925):95–97. doi: 10.1016/s0140-6736(75)90003-3. [DOI] [PubMed] [Google Scholar]
- Fisher B., Slack N., Katrych D., Wolmark N. Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy. Surg Gynecol Obstet. 1975 Apr;140(4):528–534. [PubMed] [Google Scholar]
- GEHAN E. A. A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. Biometrika. 1965 Jun;52:203–223. [PubMed] [Google Scholar]
- NISSEN-MEYER R. PROPHYLACTIC ENDOCRINE TREATMENT IN CARCINOMA OF THE BREAST. Clin Radiol. 1964 Apr;15:152–160. doi: 10.1016/s0009-9260(64)80031-3. [DOI] [PubMed] [Google Scholar]
- Ravdin R. G., Lewison E. F., Slack N. H., Dao T. L., Gardner B., State D., Fisher B. Results of a clinical trial concerning the worth of prophylactic oophorectomy for breast carcinoma. Surg Gynecol Obstet. 1970 Dec;131(6):1055–1064. [PubMed] [Google Scholar]